Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases

Clinical trial NCT07581912 · RECRUITING

Trial details

NCT number

NCT07581912

Sponsor

Zhejiang University

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-04-30

Primary completion

2028-12-01

Enrollment

40

View on ClinicalTrials.gov